Izhar Wallach
About Izhar Wallach
Izhar Wallach is the Chief Technology Officer and Co-Founder with a strong background in computer science and molecular docking, holding degrees from the University of Toronto and the Israel Institute of Technology.
Izhar Wallach Chief Technology Officer and Co-Founder
Izhar Wallach holds the title of Chief Technology Officer (CTO) and Co-Founder. He brings extensive expertise to his role, combining a deep academic background with practical experience in the industry. As a key figure in his organization, Wallach integrates advanced technology solutions with company strategies, ensuring innovative growth and development.
Education: University of Toronto and Technion
Izhar Wallach received his B.Sc. in Computer Science from the Israel Institute of Technology (Technion). He furthered his education at the University of Toronto, earning both a Master's and Ph.D. His doctoral research centered on developing algorithms to reduce biases in molecular docking, contributing to the field of computational biology. Wallach's educational background provides a strong foundation for his work in technology and drug discovery.
Research on Algorithms for Reducing Biases in Molecular Docking
Izhar Wallach's Ph.D. research at the University of Toronto focused on creating algorithms aimed at reducing biases in molecular docking. This work has significant implications for computational chemistry and drug discovery, optimizing processes for identifying potential drug candidates. His contributions in this area have been recognized through numerous publications in scientific journals.
Publications in Scientific Journals
Izhar Wallach's research achievements include extensive publication in multiple scientific journals. These publications demonstrate his contributions to the fields of computational chemistry and drug discovery, particularly through his work on molecular docking algorithms. Wallach's published research serves as a valuable resource for fellow scientists and industry professionals.
Industrial Research at Keddem Bioscience
Izhar Wallach gained industrial research experience at Keddem Bioscience, a start-up focused on small-molecule drug discovery. During his tenure, Wallach developed novel algorithms for pharmacophore inference and designed universal screening libraries. These innovations have supported the identification and development of new drug candidates, highlighting his ability to apply academic knowledge to practical industry challenges.